Matches in SemOpenAlex for { <https://semopenalex.org/work/W2287455833> ?p ?o ?g. }
- W2287455833 endingPage "612" @default.
- W2287455833 startingPage "603" @default.
- W2287455833 abstract "The diverse clinical picture of PsA suggests the need to identify suitable therapies to address the different combinations of clinical manifestations. This review aimed to classify the available biologic agents and new small molecule inhibitors (licensed and nonlicensed) based on their proven efficacy in treating different clinical manifestations associated with psoriasis and PsA. This review presents the level of evidence of efficacy of different biologic treatments and small molecule inhibitors for certain clinical features of treatment of PsA and psoriasis, which was graded in categories I-IV. The literature searches were performed on the following classes of biologic agents and small molecules: TNF inhibitors (adalimumab, etanercept, infliximab, golimumab, certolizumab), anti-IL12/IL23 (ustekinumab), anti-IL17 (secukinumab, brodalumab, ixekizumab), anti-IL6 (tocilizumab), T cell modulators (alefacept, efalizumab, abatacept, itolizumab), B cell depletion therapy (rituximab), phosphodiesterase 4 inhibitor (apremilast) and Janus kinase inhibitor (tofacitinib). A comprehensive table including 17 different biologic agents and small molecule inhibitors previously tested in psoriasis and PsA was generated, including the level of evidence of their efficacy for each of the clinical features included in our review (axial and peripheral arthritis, enthesitis, dactylitis, and nail and skin disease). We also proposed a limited set of recommendations for a sequential biologic treatment algorithm for patients with PsA who failed the first anti-TNF therapy, based on the available literature data. There is good evidence that many of the biologic treatments initially tested in psoriasis are also effective in PsA. Further research into both prognostic biomarkers and patient stratification is required to allow clinicians the possibility to make better use of the various biologic treatment options available. This review showed that there are many potentially new treatments that are not included in the current guidelines that can be used for selected categories of patients based on their disease phenotype, clinician experience and access to new biologic therapies." @default.
- W2287455833 created "2016-06-24" @default.
- W2287455833 creator A5018043626 @default.
- W2287455833 creator A5055961944 @default.
- W2287455833 creator A5083838326 @default.
- W2287455833 date "2016-02-18" @default.
- W2287455833 modified "2023-10-15" @default.
- W2287455833 title "Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies" @default.
- W2287455833 cites W1541913191 @default.
- W2287455833 cites W1556032213 @default.
- W2287455833 cites W1560520727 @default.
- W2287455833 cites W1572018981 @default.
- W2287455833 cites W1759089328 @default.
- W2287455833 cites W1765384122 @default.
- W2287455833 cites W1768811307 @default.
- W2287455833 cites W1809686743 @default.
- W2287455833 cites W1872411639 @default.
- W2287455833 cites W1922566561 @default.
- W2287455833 cites W1965032245 @default.
- W2287455833 cites W1970076597 @default.
- W2287455833 cites W1973040111 @default.
- W2287455833 cites W1973354423 @default.
- W2287455833 cites W1975463338 @default.
- W2287455833 cites W1979732206 @default.
- W2287455833 cites W1981700374 @default.
- W2287455833 cites W1994006997 @default.
- W2287455833 cites W1996190935 @default.
- W2287455833 cites W2003268049 @default.
- W2287455833 cites W2008984680 @default.
- W2287455833 cites W2012980289 @default.
- W2287455833 cites W2014381340 @default.
- W2287455833 cites W2023773454 @default.
- W2287455833 cites W2028995090 @default.
- W2287455833 cites W2031157372 @default.
- W2287455833 cites W2032220015 @default.
- W2287455833 cites W2033881749 @default.
- W2287455833 cites W2035743068 @default.
- W2287455833 cites W2045317929 @default.
- W2287455833 cites W2047729613 @default.
- W2287455833 cites W2049183898 @default.
- W2287455833 cites W2050501917 @default.
- W2287455833 cites W2053127888 @default.
- W2287455833 cites W2061084002 @default.
- W2287455833 cites W2063627867 @default.
- W2287455833 cites W2063671947 @default.
- W2287455833 cites W2080237150 @default.
- W2287455833 cites W2088155036 @default.
- W2287455833 cites W2091422666 @default.
- W2287455833 cites W2091442391 @default.
- W2287455833 cites W2094124191 @default.
- W2287455833 cites W2097007448 @default.
- W2287455833 cites W2097390734 @default.
- W2287455833 cites W2097973532 @default.
- W2287455833 cites W2098835966 @default.
- W2287455833 cites W2098927200 @default.
- W2287455833 cites W2101868943 @default.
- W2287455833 cites W2102591216 @default.
- W2287455833 cites W2103750969 @default.
- W2287455833 cites W2107510226 @default.
- W2287455833 cites W2108984264 @default.
- W2287455833 cites W2112031699 @default.
- W2287455833 cites W2113317539 @default.
- W2287455833 cites W2115041506 @default.
- W2287455833 cites W2116956799 @default.
- W2287455833 cites W2123406612 @default.
- W2287455833 cites W2126798127 @default.
- W2287455833 cites W2127834887 @default.
- W2287455833 cites W2128119287 @default.
- W2287455833 cites W2128457788 @default.
- W2287455833 cites W2129257749 @default.
- W2287455833 cites W2130925114 @default.
- W2287455833 cites W2131899204 @default.
- W2287455833 cites W2133696182 @default.
- W2287455833 cites W2135530788 @default.
- W2287455833 cites W2137101132 @default.
- W2287455833 cites W2140061052 @default.
- W2287455833 cites W2142047646 @default.
- W2287455833 cites W2142329760 @default.
- W2287455833 cites W2146843653 @default.
- W2287455833 cites W2147841297 @default.
- W2287455833 cites W2149168537 @default.
- W2287455833 cites W2158998079 @default.
- W2287455833 cites W2160512516 @default.
- W2287455833 cites W2162249611 @default.
- W2287455833 cites W2163232748 @default.
- W2287455833 cites W2164421909 @default.
- W2287455833 cites W2164533070 @default.
- W2287455833 cites W2165657093 @default.
- W2287455833 cites W2166077573 @default.
- W2287455833 cites W2167305078 @default.
- W2287455833 cites W2167795826 @default.
- W2287455833 cites W2168505126 @default.
- W2287455833 cites W2168698481 @default.
- W2287455833 cites W2168911501 @default.
- W2287455833 cites W2170800858 @default.
- W2287455833 cites W2171122996 @default.
- W2287455833 cites W2172257129 @default.
- W2287455833 cites W2181423112 @default.